Genex Pharmaceutical, Inc.
GENX · OTC
12/31/2007 | 9/30/2007 | 6/30/2007 | 3/31/2007 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 4.1% | 14.4% | 2.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 90.4% | 91.6% | 86.7% | 85.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $0 | $0 |
| Operating Income | -$0 | $0 | $0 | $0 |
| % Margin | -8.9% | 9.4% | 26.8% | 36% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -8.1% | 6.8% | 21% | 27.1% |
| EPS | -0.004 | 0.003 | 0.01 | 0.01 |
| % Growth | -224.2% | -67% | 0% | – |
| EPS Diluted | -0.004 | 0.003 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 18 | 18 | 18 | 18 |
| Weighted Avg Shares Out Dil | 18 | 18 | 18 | 18 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 14.7% | 11% | 28.6% | 37.8% |